HAG
ABBV icon

HighPoint Advisor Group’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$33.5M Buy
180,370
+5,604
+3% +$1.04M 1.78% 7
2025
Q1
$33.8M Buy
174,766
+833
+0.5% +$161K 1.97% 6
2024
Q4
$33.3M Sell
173,933
-1,193
-0.7% -$229K 1.81% 7
2024
Q3
$34.6M Sell
175,126
-3,287
-2% -$649K 2.02% 6
2024
Q2
$33.3M Buy
178,413
+2,050
+1% +$383K 1.99% 6
2024
Q1
$28.4M Buy
176,363
+262
+0.1% +$42.3K 2.01% 6
2023
Q4
$31.4M Buy
+176,101
New +$31.4M 2.25% 6
2022
Q2
$25.1M Buy
+164,743
New +$25.1M 2.75% 5
2021
Q3
$18.8M Buy
174,109
+2,840
+2% +$306K 1.84% 8
2021
Q2
$19.3M Buy
171,269
+722
+0.4% +$81.3K 1.94% 6
2021
Q1
$18.3M Sell
170,547
-24,362
-12% -$2.62M 2.12% 6
2020
Q4
$20.5M Buy
194,909
+86,948
+81% +$9.16M 2.5% 5
2020
Q3
$10.1M Buy
107,961
+10,872
+11% +$1.02M 1.83% 7
2020
Q2
$9.63M Buy
97,089
+4,456
+5% +$442K 2.06% 6
2020
Q1
$7.74M Buy
92,633
+2,806
+3% +$235K 1.84% 10
2019
Q4
$7.9M Buy
89,827
+10,545
+13% +$927K 1.63% 12
2019
Q3
$6.76M Buy
79,282
+7,325
+10% +$624K 1.49% 12
2019
Q2
$4.89M Sell
71,957
-649
-0.9% -$44.1K 1.15% 18
2019
Q1
$5.66M Buy
72,606
+6,011
+9% +$469K 1.39% 15
2018
Q4
$5.36M Buy
66,595
+1,359
+2% +$109K 1.42% 15
2018
Q3
$5.5M Sell
65,236
-1,289
-2% -$109K 1.51% 11
2018
Q2
$6.53M Sell
66,525
-1,259
-2% -$124K 1.76% 9
2018
Q1
$6.81M Buy
67,784
+21,140
+45% +$2.12M 1.87% 8
2017
Q4
$5.22M Sell
46,644
-929
-2% -$104K 1.49% 13
2017
Q3
$4.33M Sell
47,573
-13,126
-22% -$1.19M 1.34% 13
2017
Q2
$4.31M Hold
60,699
1.39% 15
2017
Q1
$4.31M Buy
60,699
+4,425
+8% +$314K 1.39% 15
2016
Q4
$3.54M Buy
56,274
+657
+1% +$41.3K 1.14% 17
2016
Q3
$3.43M Buy
55,617
+35,402
+175% +$2.18M 1.21% 15
2016
Q2
$1.24M Hold
20,215
0.44% 56
2016
Q1
$1.24M Buy
20,215
+2,571
+15% +$158K 0.76% 32
2015
Q4
$1.04M Buy
17,644
+28
+0.2% +$1.65K 0.68% 35
2015
Q3
$958K Buy
+17,616
New +$958K 1.06% 24